Search - tctmd.com

Displaying 61 - 80 of 602

Sort: Relevancy | Date

Presentation TCT 2021

TCT 677: Renal denervation in a young patient with malignant hypertension

Presenter: Maria Antonieta Lopes

November 04, 2021

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Conference News TCT 2021

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

L.A. McKeown

October 22, 2021

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

Todd Neale

September 17, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Conference News ACC 2021

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Michael O'Riordan

May 16, 2021

News Conference News AHA 2020

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Michael O'Riordan

November 17, 2020

News Conference News TCT 2020

Treating Accessory Arteries May Be Important in Renal Denervation

Todd Neale

October 18, 2020

News Daily News

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Michael O'Riordan

September 24, 2020

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

News Daily News

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

L.A. McKeown

August 21, 2020

News Conference News CRT 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

L.A. McKeown

February 27, 2020

Presentation TCT 2019

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

Presenter: Carlo Briguori

September 29, 2019

CIN Prevention II: Clinical Trials Summary of Completed and Ongoing Studies

Presentation TCT 2019

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

Presenter: Somjot Brar

September 28, 2019

Presentation TCT 2019

CIN Prevention II: IV Fluids

Presenter: Carlo Briguori

September 28, 2019

CIN Prevention III: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presentation TCT 2019

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

Presenter: Ziad Ali

September 28, 2019

Presentation TCT 2019

CIN Risk Prediction and Outcomes

Presenter: Sripal Bangalore

September 28, 2019

Presentation TCT 2019

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Presenter: Richard Solomon

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation III: Pythagoras

Presenter: Joost Daemen

September 28, 2019

Presentation TCT 2019

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Presenter: Robert Schwartz

September 28, 2019

Advertisement

TCT 677: Renal denervation in a young patient with malignant hypertension

November 2021 News Roundup

NSTEMI Patients With CKD See Better Outcomes With Invasive Strategy

Renal Denervation a Third Option for Hypertension, European Experts Say

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

Renal Denervation Lowers BP vs Sham Procedure: RADIANCE-HTN TRIO

Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials

Treating Accessory Arteries May Be Important in Renal Denervation

VERTIS CV: Ertugliflozin Meets Noninferiority Endpoint but Misses Other Marks

Renal Function Gains Seen in CKD Patients After TAVR

Longer Patency, Fewer Repeat Procedures With Paclitaxel DCBs in Dialysis Patients

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

REMEDIAL III: A Randomized Trial of Urine Flow Rate-Guided vs. LVEDP-Guided Hydration in Patients at High Risk for Contrast Nephropathy

CIN Prevention III: Clinical Trials Summary of Completed and Ongoing Studies

CIN Prevention II: IV Fluids

CIN Prevention I: Contrast Reduction Strategies, Devices, and Zero Contrast PCI (Step-by-Step)

CIN Risk Prediction and Outcomes

Contrast-Induced Nephropathy: Does It Exist and Does It Matter?

Sensing Renal Nerve Activity Before, During, and After Denervation III: Pythagoras

Sensing Renal Nerve Activity Before, During, and After Denervation I: Autonomix

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content